PMID: 6409459May 1, 1983Paper

Testicular damage after radioactive iodine (I-131) therapy for thyroid cancer

Clinical Endocrinology
D J Handelsman, J R Turtle

Abstract

Testicular damage was evaluated in twelve men by determination of sperm counts, serum FSH, LH, and testosterone up to 3 1/2 years after treatment with radioactive iodine (131I) therapy for thyroid cancer. Dose-dependent spermatogenic damage with elevation of serum FSH was evident. Full recovery in one and partial recovery in another patient was documented during 2 1/2 years of follow-up. Serial study in two patients documented a small but significant effect of 50 mCi 131I on serum FSH levels and clinically important effects appear to be restricted to men having multiple doses totalling over 100 mCi.

References

Jan 23, 1975·The New England Journal of Medicine·A M SafaA Rodriguez-Antunez
Jun 1, 1978·Australian and New Zealand Journal of Medicine·H P RoeserA J Smith
May 1, 1979·The Journal of Clinical Endocrinology and Metabolism·G S KiddR A Vigersky
Jun 1, 1978·The Annals of Thoracic Surgery·W G Trapp, C A Taunton
Oct 29, 1970·The New England Journal of Medicine·A HayekJ D Crawford
Aug 1, 1971·Fertility and Sterility·L Dubin, R D Amelar
May 1, 1974·The Journal of Clinical Endocrinology and Metabolism·D M de KretserB Hudson
Dec 1, 1966·The British Journal of Radiology·T F Sandeman
May 1, 1981·Clinical Endocrinology·D J HandelsmanJ R Turtle
Apr 1, 1980·The British Journal of Radiology·P Ash
Jul 1, 1980·Annals of Internal Medicine·R L SchilskyR C Young
Sep 1, 1980·Cancer Treatment Reviews·S M Shalet
Aug 1, 1981·The Journal of Urology·J V ThachilW D Rider
Dec 6, 1980·British Medical Journal·D J HandelsmanJ R Turtle
Feb 1, 1962·The Journal of Clinical Endocrinology and Metabolism·F A DE LA BALZEA I GURTMAN
Sep 1, 1950·The Journal of Clinical Endocrinology and Metabolism·J B TRUNNELLR HILL
Aug 1, 1951·The Journal of Clinical Endocrinology and Metabolism·G S KURLAND, A S FREEDBERG
Nov 1, 1951·The Journal of Clinical Endocrinology and Metabolism·B M DOBYNS, F MALOOF
Nov 1, 1949·The Journal of Clinical Endocrinology and Metabolism·J B TRUNNELL, L D MARINELLI

❮ Previous
Next ❯

Citations

Oct 1, 1988·World Journal of Surgery·S LennquistS Smeds
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L A Akslen, E Glattre
Dec 13, 1984·The New England Journal of Medicine·S R Ahmed, S M Shalet
Sep 13, 2002·Thyroid : Official Journal of the American Thyroid Association·Wellington Hung, Nicholas J Sarlis
May 15, 2004·Thyroid : Official Journal of the American Thyroid Association·A Wayne Meikle
Nov 25, 2003·Cancer Biotherapy & Radiopharmaceuticals·Jason B CohenI Ross McDougall
Aug 8, 2006·Thyroid : Official Journal of the American Thyroid Association·Pedro W S RosárioSaulo Purisch
Nov 7, 1992·BMJ : British Medical Journal·M H Wheeler
Apr 1, 1985·Postgraduate Medical Journal·S R Ahmed, S M Shalet
May 28, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Jaap J M TeunissenDik J Kwekkeboom
Jan 1, 1986·The British Journal of Radiology·C J Edmonds, T Smith
Feb 9, 2011·Fertility and Sterility·Chrissa Sioka, Andreas Fotopoulos
Feb 1, 1985·Clinics in Endocrinology and Metabolism·D J Handelsman, R S Swerdloff
Aug 4, 2007·Endocrinology and Metabolism Clinics of North America·Catherine Dinauer, Gary L Francis
Sep 21, 2006·Clinical Endocrinology·Claudia CeccarelliPaolo Vitti
May 26, 2004·Best Practice & Research. Clinical Endocrinology & Metabolism·Gerasimos E Krassas, Nikolaos Pontikides
Jun 20, 2002·Clinical Endocrinology·Stephen HyerClive Harmer
Aug 31, 2002·Clinical Endocrinology·Ernest L Mazzaferri
Feb 23, 2018·Thyroid : Official Journal of the American Thyroid Association·Iris YaishKaren M Tordjman
Feb 19, 2005·Journal of Surgical Oncology·Derek T Woodrum, Paul G Gauger
Nov 7, 1992·BMJ : British Medical Journal·D O'Halloran, S M Shalet
Oct 4, 2008·Current Opinion in Urology·Claudia CeccarelliPaolo Vitti
Jun 25, 2010·Endocrine Reviews·G E KrassasD Glinoer
Apr 23, 2014·Nuclear Medicine Communications·Armaghan Fard-EsfahaniMohammad Eftekhari
Nov 1, 1985·Head & Neck Surgery·L F De Keyser, A J Van Herle
Jul 5, 2003·Journal of Endocrinological Investigation·G E Krassas, P Perros
Sep 27, 2005·Arquivos brasileiros de endocrinologia e metabologia·Pedro Weslley S RosárioSaulo Purisch
Jul 20, 2005·Archives of Andrology·G E Krassas, N Pontikides
Jan 1, 1994·Clinical Genetics·Z KatoT Orii

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.